Pathways Linking Reduced Sleep Duration and Quality to Obesity Risk
|ClinicalTrials.gov Identifier: NCT00915707|
Recruitment Status : Completed
First Posted : June 8, 2009
Last Update Posted : September 5, 2013
|Condition or disease||Intervention/treatment||Phase|
|Obesity Diabetes||Other: Baseline Other: Sleep restriction Other: Reduced Sleep Quality||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||23 participants|
|Intervention Model:||Crossover Assignment|
|Official Title:||Pathways Linking Reduced Sleep Duration and Quality to Obesity Risk|
|Study Start Date :||January 2007|
|Actual Primary Completion Date :||July 2012|
|Actual Study Completion Date :||July 2012|
Subjects are tested under normal sleep conditions for carbohydrate metabolism and appetite regulation.
Subjects are allowed time in bed for sleep as their usual time at home.
Experimental: Sleep restriction
Subjects are tested under sleep restriction for carbohydrate metabolism and appetite regulation.
Other: Sleep restriction
Subjects sleep is reduced to 4.5 hours in bed for 4 nights.
Experimental: Reduced sleep quality
Subjects are tested under a poor sleep quality condition for carbohydrate metabolism and appetite regulation.
Other: Reduced Sleep Quality
Subjects sleep quality is reduced for 4 nights.
- Disposition Index reflecting Diabetes Risk as a result of decreased sleep duration and/or quality. [ Time Frame: 3 months ]
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00915707
|United States, Illinois|
|The University of Chicago|
|Chicago, Illinois, United States, 60637|
|Principal Investigator:||Esra Tasali, MD||University of Chicago|